Guide to Estradiol

WRITTEN BY
Updated: 05/22/2025|12 min read

Summary

Estradiol is the most potent and abundant form of estrogen, a group of hormones that play roles in reproductive and sexual development, particularly in women. But estradiol is also an important hormone for men.

Why It Matters

Estrogen is primarily produced by the ovaries in women, though smaller amounts are also made in the adrenal glands, fat tissue, and (in men) the testes. Estradiol levels vary widely throughout a woman's menstrual cycle, pregnancy, and lifetime, with significant changes occurring during puberty and menopause.

In women, estradiol drives physical changes during puberty, including breast development and widening of the hips. During the reproductive years, estradiol helps regulate the menstrual cycle, prepare the uterine lining for possible pregnancy, and maintain reproductive tissues.

Beyond reproduction, estradiol affects bone density by helping maintain bone mass and inhibiting bone breakdown. It influences cardiovascular health by promoting flexible blood vessels and favorable lipid profiles. It also impacts brain function, affecting mood, memory, and cognitive processes.

Measuring estradiol helps evaluate puberty timing, ovarian function, fertility challenges, menstrual irregularities, and menopause status. In men, abnormal estradiol levels may signal hormonal imbalances or certain health conditions. During fertility treatments, estradiol monitoring helps guide medication dosing and timing.

Abnormal estradiol levels can indicate various conditions. Low levels might suggest primary ovarian insufficiency, menopause, or certain genetic disorders. High levels could indicate pregnancy, certain tumors, or liver disease. In men, elevated estradiol might suggest liver disease, obesity, or certain testicular tumors.

Associated Symptoms

Estradiol levels themselves are laboratory findings rather than medical conditions. However, abnormal levels may be associated with various health issues, each with its own symptoms.

Common symptoms that may indicate conditions associated with low estradiol in women:

  • Vasomotor symptoms: Hot flashes and night sweats may be due to effects on the hypothalamic temperature regulation center
  • Vaginal changes: Dryness, thinning, and discomfort during intercourse may result from decreased tissue elasticity and lubrication
  • Menstrual irregularities: Infrequent or absent periods may result from inadequate uterine lining development
  • Mood disturbances: Depression, irritability, or anxiety can be related to estradiol's effects on neurotransmitters
  • Sleep disruption: Difficulty falling or staying asleep, may be related to night sweats or direct effects on sleep centers
  • Bone density loss: Gradual weakening of bones may be due to increased bone resorption without adequate formation
  • Cognitive changes: Memory issues or difficulty concentrating can result

Common symptoms that may indicate conditions associated with high estradiol in women:

  • Breast tenderness: Swelling and sensitivity may be due to estradiol's stimulation of breast tissue growth
  • Fluid retention: Bloating and swelling can result from estradiol's effect on sodium and water balance
  • Menstrual changes: Heavy or prolonged bleeding potentially resulting from excessive growth of the uterine lining
  • Mood swings: Emotional fluctuations may be related to hormonal effects on brain chemistry
  • Nausea: Stomach discomfort similar to morning sickness in pregnancy can be due to hormonal effects on the digestive system

Common symptoms that may indicate abnormal estradiol levels in men:

  • Gynecomastia: Development of breast tissue in males may result from excessive estradiol relative to testosterone
  • Sexual dysfunction: Decreased libido or erectile difficulties can be due to hormonal imbalance
  • Body composition changes: Increased body fat and decreased muscle mass may result from altered hormonal signaling
  • Bone health issues: Either excessive bone loss (low estradiol) or abnormal bone development (high estradiol)

It's important to understand that many factors affect hormone balance, and symptoms may result from absolute hormone levels or from imbalances between estradiol and other hormones like progesterone and testosterone. The pattern, timing, and progression of symptoms, along with laboratory findings, help determine appropriate evaluation and treatment approaches.

Clinical Ranges

Female:

  • Follicular Phase: 19-144 pg/mL
  • Mid-Cycle: 64-357 pg/mL
  • Luteal Phase: 56-214 pg/mL
  • Postmenopausal: ≤31 pg/mL

Male:

  • Lab Reference Range: ≤39 pg/mL

Lifestyle Factors That Can Impact It

Activities that may increase estradiol levels include the following:

  • Weight gain, especially in people with a higher body fat percentage
  • Excessive alcohol consumption
  • High intake of phytoestrogen-rich foods (soy, flaxseeds, certain legumes)

Activities that may decrease estradiol levels include the following:

  • Significant weight loss or very low body fat percentage
  • Excessive exercise, especially in women (can lead to athletic amenorrhea)
  • Very low-calorie diets
  • Smoking appears to lower estrogen in women but increases it in men.

Other Factors That Can Impact It

Medical Conditions

  • Polycystic ovary syndrome (PCOS): Increases estradiol through hormonal imbalances featuring higher androgen levels that get converted to estrogens
  • Endometriosis: Endometriosis lesions can produce estradiol, potentially increasing levels.
  • Hyperthyroidism: Can increase estradiol through enhanced conversion of androgens to estrogens and altered metabolism
  • Hypothyroidism: Typically decreases estradiol through reduced ovarian stimulation and altered hormone metabolism
  • Liver disease: Raises estradiol due to impaired hormone breakdown, as the liver normally metabolizes estrogens
  • Certain tumors (ovarian, adrenal, testicular): Can dramatically increase estradiol through abnormal hormone production
  • Kidney disease: Elevates estradiol due to reduced clearance of hormones from the bloodstream

Medications

  • Oral contraceptives containing estrogen: Increase estradiol by providing synthetic estrogens, though they actually suppress natural production
  • Hormone replacement therapy: Increases estradiol by providing external sources, with dosing designed to achieve premenopausal levels
  • Gonadotropin-releasing hormone (GnRH) agonists and antagonists: Decrease estradiol by suppressing the hormonal signals that stimulate the ovaries
  • Certain antiseizure medications: Decrease estradiol through enhanced liver metabolism of hormones
  • Corticosteroids: Can decrease estradiol through suppression of pituitary hormones that stimulate the ovaries

Testing Accuracy and Stability

Several factors can influence estradiol testing. It's important to be aware of these when interpreting results.

Factors That Can Affect the Accuracy of Your Test

  • The phase of the menstrual cycle can dramatically impact results, with natural fluctuations between early follicular and pre-ovulatory phases, and again in the mid-luteal phase.
  • Recent sexual activity or severe stress can temporarily affect hormone levels through complex endocrine interactions.
  • Recent consumption of alcohol can temporarily increase estradiol by affecting liver metabolism.

How It Relates to Other Markers

Other tests can provide insights about health status when viewed alongside estradiol results. These tests may include:

  • Follicle-stimulating hormone (FSH): FSH works with estradiol in feedback loops. High FSH with low estradiol may suggest primary ovarian insufficiency. Low FSH with low estradiol may suggest pituitary issues.
  • Luteinizing hormone (LH): The LH:FSH ratio helps distinguish between conditions such as PCOS (often elevated LH relative to FSH) and other causes of hormone imbalance.
  • Progesterone: This hormone normally rises after ovulation. An abnormal estradiol:progesterone ratio may cause symptoms like PMS or irregular bleeding.
  • Testosterone: It provides insight into hormonal balance and is elevated in conditions like PCOS or certain tumors.
  • Thyroid hormones: Thyroid dysfunction can significantly impact estradiol levels and reproductive function.
  • Sex hormone binding globulin (SHBG): This marker affects how much estradiol is "free" and active in the body versus bound and less available.
  • Bone density measurements: These help assess the long-term effects of estradiol status on bone health.
  • Chronic inflammation: Inflammatory markers can help interpret estradiol results, as inflammation may suppress estradiol production and alter hormone balance through effects on the hypothalamic-pituitary-ovarian axis
  • Insulin resistance: Measures of insulin function provide context for estradiol levels, as insulin resistance is associated with altered estrogen metabolism and may contribute to conditions like PCOS that affect estradiol levels

What Results May Mean in the Context of Other Markers

  • Low estradiol with high FSH: Can indicate menopause or primary ovarian insufficiency; ovaries may no longer be responding to stimulation.
  • Low estradiol with low/normal FSH: May suggest functional hypothalamic amenorrhea (from stress, excessive exercise, or low body weight) or pituitary dysfunction.
  • High estradiol with high FSH: Might indicate laboratory error or certain rare conditions. However, sometimes this pattern occurs during early menopause.
  • High estradiol with normal/low FSH: May suggest an estrogen-producing tumor, exogenous estrogen, or certain phases of fertility treatment.
  • Normal estradiol with irregular cycles: Could indicate anovulation or luteal phase defects despite adequate estrogen.
  • Fluctuating estradiol with perimenopausal symptoms: May reflect the erratic ovarian function typical of perimenopause.

Follow-up Considerations

Your provider may work with you on a plan to address any levels that were out of range. Here are some recommendations they might make. You should always speak to your doctor if you have medical questions or before making medical decisions.

When Re-Testing May be Appropriate

  • Initial abnormal result: Often repeated to confirm findings
  • During menstrual cycle investigation: At specific points in the cycle, as directed
  • During fertility treatment: Frequently throughout the stimulation phase
  • Menopausal hormone therapy monitoring: 3--6 months after starting or adjusting treatment
  • Hormone suppression therapy (cancer): As directed, typically every 1--3 months
  • After medication changes: 4--8 weeks to assess impact

Additional Testing Your Doctor May Consider

  • Thyroid function tests
  • Prolactin level
  • Androgen panel in cases of excess body hair or other virilization signs
  • Pelvic ultrasound to evaluate ovarian structures
  • Pituitary imaging if central hormonal issues are suspected
  • Genetic testing in cases of primary ovarian insufficiency
  • Adrenal function tests if adrenal involvement is suspected

When Additional Care May be Warranted

  • Extremely high estradiol without explanation (possible tumor)
  • Premature estradiol decline in young women
  • Unexpected changes in puberty timing or progression
  • Significant vaginal bleeding with high estradiol
  • Rapidly developing symptoms of hormone imbalance
  • Severe menopausal symptoms affecting quality of life
  • Gynecomastia or feminization symptoms in men
  • Estradiol abnormalities with desire for fertility
  • Bone density concerns with low estradiol

Bibliography

References

1. Burger, Henry G. "Androgen Production in Women." Fertility and Sterility, vol. 77, suppl. 4, 2002, pp. S3-S5. DOI: 10.1016/S0015-0282(02)02985-0.​

2. Hankinson, Susan E., et al. "Circulating Concentrations of Insulin-Like Growth Factor-I and Risk of Breast Cancer." The Lancet, vol. 351, no. 9113, 1998, pp. 1393-1396. DOI: 10.1016/S0140-6736(97)10384-1.​

3. Haring, Robin, et al. "Age-Specific Reference Ranges for Serum Testosterone and Androstenedione Concentrations in Women Measured by Liquid Chromatography--Tandem Mass Spectrometry." The Journal of Clinical Endocrinology & Metabolism, vol. 97, no. 2, 2012, pp. 408-415. DOI: 10.1210/jc.2011-2134.​

4. Rosenfield, Robert L, and David A Ehrmann. "The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited." Endocrine reviews vol. 37,5 (2016): 467-520. doi:10.1210/er.2015-1104

5. Wierman, Margaret E., et al. "Androgen Therapy in Women: A Reappraisal: An Endocrine Society Clinical Practice Guideline." The Journal of Clinical Endocrinology & Metabolism, vol. 99, no. 10, 2014, pp. 3489-3510. DOI: 10.1210/jc.2014-2260.​

6. Michnovicz, Jon J., et al. "Cigarette Smoking Alters Hepatic Estrogen Metabolism in Men: Implications for Atherosclerosis." Metabolism, vol. 38, no. 6, 1989, pp. 537--541. doi:10.1016/0026-0495(89)90213-8.

7. "Menopause." Penn Center for Women's Behavioral Wellness, Perelman School of Medicine at the University of Pennsylvania, https://www.med.upenn.edu/womenswellness/menopause.html. Accessed 29 Mar. 2025.

8. Chantalat, Elodie et al. "Estrogen Receptors and Endometriosis." International journal of molecular sciences vol. 21,8 2815. 17 Apr. 2020, doi:10.3390/ijms21082815

Sign up for the Levels Newsletter